Early Lifetime Substance Use and Development of Visual Impairment: Analysis of the National Survey on Drug Use and Health Data

References

• National Survey on Drug Use and Health. Frequently asked questions. Available from: https://nsduhweb.rti.org/respweb/faq.html. Accessed December 1, 2022.
   Google Scholar
• Underwood JM, Brener N, Thornton J, et al. Overview and methods for the youth risk behavior surveillance system — United States, 2019. MMWR Suppl. 2020;69(Suppl 1):S1–S10. doi:10.15585/mmwr.su6901a1
   PubMedGoogle Scholar
• Substance Abuse and Mental Health Services Administration (US); Office of the Surgeon General (US). Facing addiction in America: the surgeon general’s report on alcohol, drugs, and health. Washington (DC): US Department of Health and Human Services; 2016. Available from: https://addiction.surgeongeneral.gov/sites/default/files/surgeon-generals-report.pdf. Accessed December 1, 2022.
   Google Scholar
• National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Adolescent and School Health. Youth risk behavior survey; 2019. Available from: https://www.cdc.gov/healthyyouth/data/yrbs/pdf/YRBSDataSummaryTrendsReport2019-508.pdf. Accessed December 1, 2022.
   Google Scholar
• Andoh J, Mir TA, Teng C, Wang EA, Nwanyanwu KH. Assessment of vision impairment among individuals with history of criminal justice involvement. Invest Ophthalmol Vis Sci. 2021;62(8):3493.
   Web of Science ®Google Scholar
• Peragallo J, Biousse V, Newman NJ. Ocular manifestations of drug and alcohol abuse. Curr Opin Ophthalmol. 2013;24(6):566–573. doi:10.1097/ICU.0b013e3283654db2
   PubMed Web of Science ®Google Scholar
• French DD, Margo CE, Harman LE. Substance use disorder and the risk of open-angle glaucoma. J Glaucoma. 2011;20(7):452–457. doi:10.1097/IJG.0b013e3181f7b134
   PubMed Web of Science ®Google Scholar
• Mir TA, Papudesu C, Fang W, Hinkle DM. Incidence of drug use-related endogenous endophthalmitis hospitalizations in the United States, 2003 to 2016. JAMA Ophthalmol. 2021;139(1):18–26. doi:10.1001/jamaophthalmol.2020.4741
   PubMed Web of Science ®Google Scholar
• Orum MH, Kalenderoglu A. Acute opioid use may cause choroidal thinning and retinal nerve fiber layer increase. J Addict Dis. 2021;39(3):322–330. doi:10.1080/10550887.2021.1874816
   PubMed Web of Science ®Google Scholar
• Kim RW, Juzych MS, Eliott D. Ocular manifestations of injection drug use. Infect Dis Clin North Am. 2002;16(3):607–622. doi:10.1016/S0891-5520(02)00013-2
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim JH, Nam WH, et al. Oral alcohol administration disturbs tear film and ocular surface. Ophthalmology. 2012;119(5):965–971. doi:10.1016/j.ophtha.2011.11.015
   PubMed Web of Science ®Google Scholar
• Karimi S, Arabi A, Shahraki T. Alcohol and the eye. J Ophthalmic Vis Res. 2021;16(2):260–270. doi:10.18502/jovr.v16i2.9089
   PubMed Web of Science ®Google Scholar
• Nguyen AX, Wu AY. Cannabis and the cornea. Ocul Immunol Inflamm. 2021;29(5):1023–1028. doi:10.1080/09273948.2020.1726969
   PubMed Web of Science ®Google Scholar
• Centers for Medicare & Medicare Services. National survey on drug use and health (NSDUH); 2019. Available from: https://www.cms.gov/About-CMS/Agency-Information/OMH/resource-center/hcps-and-researchers/data-tools/sgm-clearinghouse/nsduh. Accessed December 1, 2022.
   Google Scholar
• U.S. Department of Health & Human Services. Substance abuse and mental health services administration (SAMHSA); 2019. Available from: https://www.samhsa.gov/. Accessed December 1, 2022.
   Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). NSDUH data use; 2019. Available from: https://nsduhweb.rti.org/respweb/datause.html. Accessed December 1, 2022.
   Google Scholar
• U.S. Department of Health & Human Services. FY 2021 annual performance plan and report - goal 2 objective 3; 2021. Available from: https://www.hhs.gov/about/budget/fy2021/performance/performance-plan-goal-2-objective-3/index.html. Accessed December 1, 2022.
   Google Scholar
• Office of National Drug Control Policy. National drug control strategy; 2016. Available from: https://obamawhitehouse.archives.gov/ondcp/policy-and-research/ndcs#:~:text=The%20National%20Drug%20Control%20Strategy. Accessed December 1, 2022.
   Google Scholar
• Han BH, Leddy JF, Lopez FA, Palamar JJ. Prevalence of psychoactive substance use among middle-aged and older adults with visual impairment in the US. JAMA Ophthalmol. 2022;140(1):94–95. doi:10.1001/jamaophthalmol.2021.4667
   PubMed Web of Science ®Google Scholar
• Key substance use and mental health indicators in the United States: results from the 2015 national survey on drug use and health. SAMHSA.gov; 2015. Available from: https://www.samhsa.gov/data/sites/default/files/NSDUH-FFR1-2015/NSDUH-FFR1-2015/NSDUH-FFR1-2015.pdf. Accessed December 1, 2022.
   Google Scholar
• Kelly JF, Myers MG. Adolescents’ participation in alcoholics anonymous and narcotics anonymous: review, implications and future directions. J Psychoactive Drugs. 2007;39(3):259–269. doi:10.1080/02791072.2007.10400612
   PubMed Web of Science ®Google Scholar
• McDaniel JT, Jenkins WD, Albright DL, Null D, McIntosh S, McDaniel MR. Illicit drug use and self-reported vision loss among military service members or veterans. BMJ Mil Health. 2020;25:bmjmilitary-2020–001518.
   Google Scholar
• SAMHDA. National survey on drug use and health 2020 (NSDUH-2020-DS0001); 2020. Available from: https://www.datafiles.samhsa.gov/dataset/national-survey-drug-use-and-health-2020-nsduh-2020-ds0001. Accessed December 1, 2022.
   Google Scholar
• American Academy of Ophthalmology. Survey reveals most Americans know a lot less about eye health than they think they do: here’s why that’s a problem; 2020. Available from: https://www.aao.org/newsroom/news-releases/detail/survey-reveals-most-americans-know-less-eye-health. Accessed December 1, 2022.
   Google Scholar
• Kumar V, Abbas AK, Fausto N, et al. Robbins and Cotran Pathologic Basis of Diseases. 10th ed. Chicago: Elsevier Saunders; 2005.
   Google Scholar
• CDC. Understanding the epidemic: CDC’s response to the opioid overdose epidemic; 2022. Available from: https://www.cdc.gov/opioids/basics/epidemic.html. Accessed December 1, 2022.
   Google Scholar
• Jones CM, Compton WM, Mustaquim D. Patterns and characteristics of methamphetamine use among adults — United States, 2015–2018. MMWR Morb Mortal Wkly Rep. 2020;69(12):317–323. doi:10.15585/mmwr.mm6912a1
   PubMed Web of Science ®Google Scholar
• Palamar JJ, Davies S, Ompad DC, Cleland CM, Weitzman M. Powder cocaine and crack use in the United States: an examination of risk for arrest and socioeconomic disparities in use. Drug Alcohol Depend. 2015;149:108–116. doi:10.1016/j.drugalcdep.2015.01.029
   PubMed Web of Science ®Google Scholar
• Butler AJ, Rehm J, Fischer B. Health outcomes associated with crack-cocaine use: systematic review and meta-analyses. Drug Alcohol Depend. 2017;180:401–416. doi:10.1016/j.drugalcdep.2017.08.036
   PubMed Web of Science ®Google Scholar
• Luong PM, Tsui E, Batra NN, Zegans ME. Endogenous endophthalmitis and other ocular manifestations of injection drug use. Curr Opin Ophthalmol. 2019;30(6):506–512. doi:10.1097/ICU.0000000000000606
   PubMed Web of Science ®Google Scholar
• Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118(9):1264–1268. doi:10.1001/archopht.118.9.1264
   PubMed Web of Science ®Google Scholar
• Cumurcu T, Gunduz A, Cumurcu BE, Gul IG, Akpolat N, Karlidag R. The changes in tear film parameters and impression cytology in heavily drinking men. Cornea. 2013;32(3):237–241. doi:10.1097/ICO.0b013e31825239d1
   PubMed Web of Science ®Google Scholar
• Engster SA, Bogen DL, Molina BSG. Adolescent and parent management of controlled prescription medications. Subst Use Misuse. 2019;54(14):2264–2274. doi:10.1080/10826084.2019.1645176
   PubMed Web of Science ®Google Scholar
• Mayo Clinic. Drug addiction (substance use disorder) - symptoms and causes. Mayo Clinic; 2022. Available from: https://www.mayoclinic.org/diseases-conditions/drug-addiction/symptoms-causes/syc-20365112. Accessed December 1, 2022.
   Google Scholar
• Kandel ER, Kandel DB, Molecular A. Basis for nicotine as a gateway drug. N Engl J Med. 2014;371(10). doi:10.1056/NEJMsa1405092
   Web of Science ®Google Scholar
• Degenhardt L, Dierker L, Chiu WT, et al. Evaluating the drug use “gateway” theory using cross-national data: consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys. Drug Alcohol Depend. 2010;108(1–2):84–97. doi:10.1016/j.drugalcdep.2009.12.001
   PubMed Web of Science ®Google Scholar
• Martin CS. Timing of alcohol and other drug use. Alcohol Res Health. 2008;31(2):96–99.
   PubMedGoogle Scholar
• Barry AE, King J, Sears C, Harville C, Bondoc I, Joseph K. Prioritizing alcohol prevention: establishing alcohol as the gateway drug and linking age of first drink with illicit drug use. J Sch Health. 2016;86(1):31–38. doi:10.1111/josh.12351
   PubMed Web of Science ®Google Scholar
• Secades-Villa R, Garcia-Rodríguez O, Jin CJ, Wang S, Blanco C. Probability and predictors of the cannabis gateway effect: a national study. Int J Drug Policy. 2015;26(2):135–142. doi:10.1016/j.drugpo.2014.07.011
   PubMed Web of Science ®Google Scholar
• Sinha R. Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci. 2008;1141:105. doi:10.1196/annals.1441.030
   PubMed Web of Science ®Google Scholar
• Litt MD, Kadden RM, Tennen H, Dunn HK. Momentary coping and marijuana use in treated adults: exploring mechanisms of treatment. J Consult Clin Psychol. 2021;89(4):264–276. doi:10.1037/ccp0000633
   PubMed Web of Science ®Google Scholar
• Litt MD, Kadden RM, Kabela-Cormier E. Individualized assessment and treatment program for alcohol dependence: results of an initial study to train coping skills. Addiction. 2009;104(11):1837–1838. doi:10.1111/j.1360-0443.2009.02693.x
   PubMed Web of Science ®Google Scholar
• Roos CR, Maisto SA, Witkiewitz K. Coping mediates the effects of cognitive-behavioral therapy for alcohol use disorder among out-patient clients in Project MATCH when dependence severity is high. Addiction. 2017;112(9):1547–1557. doi:10.1111/add.13841
   PubMed Web of Science ®Google Scholar
• Gray KM, Squeglia LM. Research review: what have we learned about adolescent substance use? J Child Psychol Psychiatry. 2018;59(6):618–627. doi:10.1111/jcpp.12783
   PubMed Web of Science ®Google Scholar
• Feinstein EC, Richter L, Foster SE. Addressing the critical health problem of adolescent substance use through health care, research, and public policy. J Adolesc Health. 2012;50(5):431–436. doi:10.1016/j.jadohealth.2011.12.033
   PubMed Web of Science ®Google Scholar
• Harris SK, Louis-Jacques J, Knight JR. Screening and brief intervention for alcohol and other abuse. Adolesc Med State Art Rev. 2014;25(1):126–156.
   PubMedGoogle Scholar
• Han RC, Jefferis JM, Taylor JP, Archibald NK, Clarke MP. A novel, multidisciplinary clinic for complex visual problems in older people. Eye. 2012;26(12):1536–1541. doi:10.1038/eye.2012.205
   PubMed Web of Science ®Google Scholar
• Jefferis JM, Mosimann UP, Clarke MP. Cataract and cognitive impairment: a review of the literature. Br J Ophthalmol. 2011;95(1):17–23. doi:10.1136/bjo.2009.165902
   PubMed Web of Science ®Google Scholar
• Lalanne L, Ferrand-Devouge E, Kirchherr S, et al. Impaired contrast sensitivity at low spatial frequency in cannabis users with early onset. Eur Neuropsychopharmacol. 2017;27(12):1289–1297. doi:10.1016/j.euroneuro.2017.09.006
   PubMed Web of Science ®Google Scholar